Analysis conducted on samples retrieved from the TCGA database revealed a significant increase in the proportion of neutrophils, resting memory CD4+ T cells, regulatory T-cells (Tregs), and M2 macrophages in the high-immunity group of glioma patients (Figure 9A). This evidence concerns the gene CD4 and glioma.